Home >> Industry News >> Sysmex gets FDA clearance for residual WBC counting 

Sysmex gets FDA clearance for residual WBC counting 

image_pdfCreate PDF

June 15, 2022—The FDA has cleared residual white blood cell counting on Sysmex America’s XN-10 Automated Hematology Analyzer with Blood Bank mode. The analyzer supports red blood cell and platelet component testing along with residual white blood cell counting in a single sample aspiration with no sample preparation or predilution required and offers four selectable profiles, two for red blood cell concentrates and two for platelet concentrates.

CAP TODAY
X